Source:http://linkedlifedata.com/resource/pubmed/id/18245665
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2008-3-25
|
pubmed:abstractText |
ABO blood groups greatly influence circulating von Willebrand factor (VWF) levels, and O group subjects have lower VWF values. In this study, we investigated whether ABO groups affect VWF survival by monitoring the post-DDAVP (1-desamino-8-d arginine vasopressin) time courses of VWF antigen (VWF:Ag), VWF collagen binding (VWF:CB), and factor VIII (FVIII) in 47 healthy subjects (28 O and 19 non-O blood groups). The elimination half-life (T1/2el) of VWF was found significantly shorter in O than in non-O subjects (10.0+/-0.8 hours vs 25.5+/-5.3 hours, respectively; P<.01), as was the T1/2el of VWF:CB (7.9+/-0.5 hours vs 20.9+/-4.5 hours; P<.01). A direct linear correlation was found between basal VWF:Ag and T1/2el, subjects with higher VWF levels having longer-surviving VWF. ABO blood groups appeared to strongly influence VWF clearance, but not its synthesis or release from endothelial cells. The VWF propeptide to VWF:Ag ratio, useful for predicting an increased VWF clearance, was found significantly higher in O than in non-O individuals (1.6+/-0.1 vs 1.2+/-0.5, P<.001), with values that correlated inversely with T1/2el (P<.001). Based on these findings, we conclude that the lower VWF values in O group individuals is attributable to a shorter VWF survival and circulating VWF values are strongly influenced by its half-life.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ABO Blood-Group System,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Deamino Arginine Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/Hemostatics,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0006-4971
|
pubmed:author |
pubmed-author:BertomoroAntonellaA,
pubmed-author:CasonatoAlessandraA,
pubmed-author:CattiniMaria GraziaMG,
pubmed-author:DaidoneVivianaV,
pubmed-author:GallinaroLisaL,
pubmed-author:PadriniRobertoR,
pubmed-author:PagnanAntonioA,
pubmed-author:PontaraElenaE,
pubmed-author:SartorelloFrancescaF,
pubmed-author:SztukowskaMarytaM
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
111
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3540-5
|
pubmed:meshHeading |
pubmed-meshheading:18245665-ABO Blood-Group System,
pubmed-meshheading:18245665-Collagen,
pubmed-meshheading:18245665-Deamino Arginine Vasopressin,
pubmed-meshheading:18245665-Endothelial Cells,
pubmed-meshheading:18245665-Female,
pubmed-meshheading:18245665-Half-Life,
pubmed-meshheading:18245665-Hemostatics,
pubmed-meshheading:18245665-Humans,
pubmed-meshheading:18245665-Male,
pubmed-meshheading:18245665-Protein Binding,
pubmed-meshheading:18245665-von Willebrand Factor
|
pubmed:year |
2008
|
pubmed:articleTitle |
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.
|
pubmed:affiliation |
Department of Medical and Surgical Sciences, University of Padua Medical School, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|